Navigation Links
New way to kill lymphoma without chemotherapy
Date:1/21/2013

CHICAGO --- How do you annihilate lymphoma without using any drugs?

Starve it to death by depriving it of what appears to be a favorite food: HDL cholesterol.

Northwestern Medicine researchers discovered this with a new nanoparticle that acts like a secret double agent. It appears to the cancerous lymphoma cell like a preferred meal -- natural HDL. But when the particle engages the cell, it actually plugs it up and blocks cholesterol from entering. Deprived of an essential nutrient, the cell eventually dies.

A new study by C. Shad Thaxton, M.D., and Leo I. Gordon, M.D. shows that synthetic HDL nanoparticles killed B-cell lymphoma, the most common form of the disease, in cultured human cells, and inhibited human B-cell lymphoma tumor growth in mice.

The paper will be published Jan. 21 in the journal Proceedings of the National Academy of Sciences.

"This has the potential to eventually become a nontoxic treatment for B-cell lymphoma which does not involve chemotherapy," said Gordon, a co-corresponding author with Thaxton on the paper. "It's an exciting preliminary finding."

Gordon is a professor of medicine in hematology/oncology and Thaxton is an assistant professor of urology, both at Northwestern University Feinberg School of Medicine.

Gordon also is co-director of the hematologic malignancy program at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and a physician at Northwestern Memorial Hospital. Thaxton is also a member of the Lurie Cancer Center.

Lymphoma Gobbles HDL Cholesterol

Recent studies have shown that B-cell lymphoma is dependent on the uptake of natural HDL -- short for high-density lipoprotein -- from which it derives fat content, such as cholesterol.

The nanoparticle -- originally developed by Thaxton as a possible therapy for heart disease -- closely mimics the size, shape and surface chemistry of natural HDL
'/>"/>

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New research helps predict susceptibility to Burkitt lymphoma
2. Duke Medicine news -- Genome sequencing of Burkitt Lymphoma reveals unique mutation
3. New key element discovered in pathogenesis of Burkitt lymphoma
4. Scientists win $2 million to study new pathway in development and maintenance of lymphoma
5. Solving puzzles without a picture
6. Not without my microbes
7. Bugs without borders
8. Production of FRP components without release agents
9. How bumblebees find efficient routes without a GPS
10. Surviving without ice
11. Survival without water: A key trait of an aquatic invader to spread
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... in fuel cell powered buses, including a team ... electrode degradation processes and bus membrane durability. , ... degradation stressors in the operating cycle of the ... of the study, led by SFU graduate student ... study at Burnaby-based Ballard Power Systems and funded ...
(Date:5/22/2013)... in a major new effort to educate the public ... people with clean water that looms ahead in the ... in the current edition of Chemical & Engineering ... Society (ACS), the world,s largest scientific society. , Bassam ... L. Schnoor, Ph.D., explain that shortages of reliable supplies ...
(Date:5/22/2013)... drastically reduces the time and effort needed to ... biotechnology, scientists are reporting. Published in the journal ... the way for more rapid development of designer ... activities. , Keith Shearwin and colleagues explain that ... material DNA into a bacterium,s genome is critical ...
Breaking Biology News(10 mins):Tests lead to doubling of fuel cell life 2
... release is available in German . ... that are crucial in fighting pathogen assault. Researchers ... the Helmholtz Centre for Environmental Research (UFZ) characterized ... class II locus in a tailed amphibian. Unlike ...
... Manchester has been successful in gaining major European ... millions of biological samples, such as DNA, can ... across Europe. The Centre for Integrated Genomic ... Translational Medicine, is playing a key role in ...
... CA Nitrogen is essential to all life on Earth, and ... determine how ecosystems respond to global warming. But certain aspects ... puzzled scientists, defying, in a sense, the laws of supply ... atmosphere often thrive where it is readily available in the ...
Cached Biology News:New findings on immune system in amphibians 2Manchester clears first hurdle in €170 million biobank building boom 2Researchers explain nitrogen paradox in forests 2
(Date:5/23/2013)... MENLO PARK, Calif. , May 23, 2013 /PRNewswire/ ... an oral treatment for pain has reached an important ... clinical trial of VBY-036 - a selective cathepsin S ... of VBY-036 is a double-blind, randomized, placebo-controlled study designed ... escalating doses of VBY-036 in healthy adults. ...
(Date:5/23/2013)... Z Trim Holdings, Inc. (OTC Markets: ZTHO), ... of industries, announced that Chef Erin Ryan ... year,s National Restaurant Association ("NRA") NRA Show, which was ... Research Chefs Association.  Chef Ryan spoke on the subject ... and the Ugly," joining four other prestigious panelists including: ...
(Date:5/23/2013)... May 23, 2013 Pressure BioSciences, Inc. (OTCQB: ... Company will host a teleconference to discuss its First ... update. The teleconference information is provided below: ... Daylight Time (EDT) Dial-in: (800) 875-3456 (U.S.); ... (Int,l) Passcode: VS22823 For those unable to ...
(Date:5/23/2013)... 2013 Pusan National University Yangsan Hospital, ... and contract research company focused on research and ... today a publication reporting the induction of functional ... and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex Inc.). ... the May 15 th , 2013 issue of ...
Breaking Biology Technology:Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3
... S.A. and,Solvay Pharmaceuticals Marketing and Licensing AG (subsidiary ... partnership agreement for the,promotion and distribution of Stallergenes ... of Independent States (CIS). , ... and a strong demand on the,part of the ...
... Md., March 24 PharmAthene, Inc. (NYSE Amex: ... against biological and chemical threats, announced today that certain ... of its common stock and warrants in a registered ... agreements, PharmAthene will sell an aggregate of 2,116,055 newly ...
... easy and safe for everyone--including Mother Earth , ... ... now have more free time following the invention of the FlameDisk, ... solid ethanol as its fuel source, lights instantaneously with the touch ...
Cached Biology Technology:Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS* 2Stallergenes Signs an Exclusive Partnership Agreement With Solvay Pharmaceuticals for the Promotion and Distribution of its Products in Russia and the CIS* 3PharmAthene Announces $5.5 Million Public Equity Offering 2PharmAthene Announces $5.5 Million Public Equity Offering 3Just Say No To Charcoal! New Eco-Friendly Alternative Grills Faster, Burns Cleaner And Greener 2